The Net Margin of Regulus Therapeutics Inc (RGLS) is -157.21%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -157.21% |
| 2023-12-31 | -157.21% |
| 2022-12-31 | -272.13% |
| 2021-12-31 | -67651.39% |
| 2020-12-31 | -99868.06% |
| 2019-12-31 | -6853.94% |
| 2018-12-31 | -268.55% |